68Ga-labeled NY104 PET Imaging in Patients
Condition(s):Renal Cell CarcinomaLast Updated:December 6, 2022Recruiting
Include Studies Not Open or Pending
Condition(s):Renal Cell CarcinomaLast Updated:December 6, 2022Recruiting
Condition(s):Kidney Cancer; Lymphomas; Positron Emission TomographyLast Updated:February 16, 2024Recruiting
Condition(s):Clear Cell Renal Cell Carcinoma; Prognostic Cancer Model; Recurrent Renal Cell CancerLast Updated:February 22, 2024Recruiting
Condition(s):Renal Cell Carcinoma; Urothelial Carcinoma; Cervical Cancer; Ovarian Cancer Recurrent; Endometrial CancerLast Updated:July 1, 2022Recruiting
Condition(s):Stage I Renal Cell Cancer; Stage II Renal Cell CancerLast Updated:June 9, 2023Recruiting
Condition(s):Advanced Kidney CancerLast Updated:August 8, 2022Recruiting
Condition(s):Advanced Ovarian Carcinoma; Advanced Renal Cell Carcinoma; Advanced Pancreatic Carcinoma; Advanced Colorectal Carcinoma; Metastatic Pancreatic Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Renal Cell Carcinoma; Metastatic Ovarian CarcinomaLast Updated:March 8, 2023Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:March 5, 2024Recruiting
Condition(s):Kidney Neoplasm; Renal Cancer; Inoperable DiseaseLast Updated:April 18, 2023Recruiting
Condition(s):Advanced Renal Cell CarcinomaLast Updated:December 7, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.